Carsten A Wagner
The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria.
Dhayat N, Mattmann C, Seeger H, Ritter A, Ernandez T, Stoermann-Chopard C, Buchkremer F, Segerer S, Roth B, Wuerzner G, Wagner C, Bonny O, Popp A, Vogt B, Bargagli M, Fuster D. The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria. Kidney Int Rep 2024; 9:1072-1082.
10.01.2024The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria.
10.01.2024Kidney Int Rep 2024; 9:1072-1082
Dhayat Nasser A, Mattmann Cédric, Seeger Harald, Ritter Alexander, Ernandez Thomas, Stoermann-Chopard Catherine, Buchkremer Florian, Segerer Stephan, Roth Beat, Wuerzner Gregoire, Wagner Carsten A, Bonny Olivier, Popp Albrecht W, Vogt Bruno, Bargagli Matteo, Fuster Daniel G
Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria
Rodríguez D, Gurevich E, Mohammadi Jouabadi, Pastor Arroyo E, Ritter A, Estoppey Younes S, Wagner C, Imenez Silva P, Seeger H, Mohebbi N. Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria. Clinical Kidney Journal 2023
01.11.2023Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria
01.11.2023Clinical Kidney Journal 2023
Rodríguez Daniel, Gurevich Ekaterina, Mohammadi Jouabadi Soroush, Pastor Arroyo Eva Maria, Ritter Alexander, Estoppey Younes Sandrine, Wagner Carsten A, Imenez Silva Pedro H, Seeger Harald, Mohebbi Nilufar
Differences in the Food Consumption Between Kidney Stone Formers and Nonformers in the Swiss Kidney Stone Cohort.
Legay C, Haeusermann T, Pasquier J, Chatelan A, Fuster D, Dhayat N, Seeger H, Ritter A, Mohebbi N, Ernandez T, Stoermann-Chopard C, Buchkremer F, Segerer S, Wuerzner G, Ammor N, Roth B, Wagner C, Bonny O, Bochud M. Differences in the Food Consumption Between Kidney Stone Formers and Nonformers in the Swiss Kidney Stone Cohort. J Ren Nutr 2023; 33:555-565.
27.04.2023Differences in the Food Consumption Between Kidney Stone Formers and Nonformers in the Swiss Kidney Stone Cohort.
27.04.2023J Ren Nutr 2023; 33:555-565
Legay Constance, Haeusermann Tanja, Pasquier Jérôme, Chatelan Angeline, Fuster Daniel G, Dhayat Nasser A, Seeger Harald, Ritter Alexander, Mohebbi Nilufar, Ernandez Thomas, Stoermann-Chopard Catherine, Buchkremer Florian, Segerer Stephan, Wuerzner Gregoire, Ammor Nadia, Roth Beat, Wagner Carsten A, Bonny Olivier, Bochud Murielle
The Swiss Kidney Stone Cohort (SKSC), a longitudinal, multi-centric, observational cohort to study course and causes of kidney stone disease in Switzerland.
Bonny O, Fuster D, Seeger H, Ernandez T, Buchkremer F, Wuerzner G, Dhayat N, Ritter A, Stoermann-Chopard C, Segerer S, Haeusermann T, Pasch A, Kim M, Mayr M, Krapf R, Roth B, Bochud M, Mohebbi N, Wagner C. The Swiss Kidney Stone Cohort (SKSC), a longitudinal, multi-centric, observational cohort to study course and causes of kidney stone disease in Switzerland. Kidney Blood Press Res 2023
13.02.2023The Swiss Kidney Stone Cohort (SKSC), a longitudinal, multi-centric, observational cohort to study course and causes of kidney stone disease in Switzerland.
13.02.2023Kidney Blood Press Res 2023
Bonny Olivier, Fuster Daniel G, Seeger Harald, Ernandez Thomas, Buchkremer Florian, Wuerzner Gregoire, Dhayat Nasser A, Ritter Alexander, Stoermann-Chopard Catherine, Segerer Stephan, Haeusermann Tanja, Pasch Andreas, Kim Minjeong, Mayr Michael, Krapf Reto, Roth Beat, Bochud Murielle, Mohebbi Nilufar, Wagner Carsten A
Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
Mohebbi N, Ritter A, Wiegand A, Graf N, Dahdal S, Sidler D, Arampatzis S, Hadaya K, Müller T, Wagner C, Wüthrich R. Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial. Lancet 2023; 401:557-567.
25.01.2023Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
25.01.2023Lancet 2023; 401:557-567
Mohebbi Nilufar, Ritter Alexander, Wiegand Anna, Graf Nicole, Dahdal Suzan, Sidler Daniel, Arampatzis Spyridon, Hadaya Karine, Müller Thomas F, Wagner Carsten A, Wüthrich Rudolf P
Acidosis and alkali therapy in patients with kidney transplant is associated with transcriptional changes and altered abundance of genes involved in cell metabolism and acid-base balance.
Imenez Silva P, Wiegand A, Daryadel A, Russo G, Ritter A, Gaspert A, Wüthrich R, Wagner C, Mohebbi N. Acidosis and alkali therapy in patients with kidney transplant is associated with transcriptional changes and altered abundance of genes involved in cell metabolism and acid-base balance. Nephrol Dial Transplant 2021; 36:1806-1820.
27.09.2021Acidosis and alkali therapy in patients with kidney transplant is associated with transcriptional changes and altered abundance of genes involved in cell metabolism and acid-base balance.
27.09.2021Nephrol Dial Transplant 2021; 36:1806-1820
Imenez Silva Pedro H, Wiegand Anna, Daryadel Arezoo, Russo Giancarlo, Ritter Alexander, Gaspert Ariana, Wüthrich Rudolf P, Wagner Carsten A, Mohebbi Nilufar
The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation
Tcymbarevich I, Misselwitz B, de Vallière C, Rogler G, Ruiz P, Seuwen K, Scharl M, Wagner C, Kullak-Ublick G, Lang S, Cosin-Roger J, Spalinger M, Obialo N, Rossel J, Eloranta J, Swiss IBD Cohort Study Group. The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation. BMC Gastroenterol 2019; 19:2.
07.01.2019The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation
07.01.2019BMC Gastroenterol 2019; 19:2
Tcymbarevich Irina V, Misselwitz Benjamin, de Vallière Cheryl, Rogler Gerhard, Ruiz Pedro A, Seuwen Klaus, Scharl Michael, Wagner Carsten A, Kullak-Ublick Gerd A, Lang Silvia, Cosin-Roger Jesus, Spalinger Marianne, Obialo Nicole, Rossel Jean-Benoit, Eloranta Jyrki J, Swiss IBD Cohort Study Group
Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): rationale and study protocol.
Wiegand A, Ritter A, Graf N, Arampatzis S, Sidler D, Hadaya K, Müller T, Wagner C, Wüthrich R, Mohebbi N. Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): rationale and study protocol. BMC Nephrol 2018; 19:177.
13.07.2018Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): rationale and study protocol.
13.07.2018BMC Nephrol 2018; 19:177
Wiegand Anna, Ritter Alexander, Graf Nicole, Arampatzis Spyridon, Sidler Daniel, Hadaya Karine, Müller Thomas F, Wagner Carsten A, Wüthrich Rudolf P, Mohebbi Nilufar
Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice
Frebel H, Ludewig B, Kurrer M, Loffing-Cueni D, Wagner C, Vogel J, Richter K, Braunschweiler T, Schuepbach R, Nindl V, Oxenius A. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J Exp Med 2012; 209:2485-99.
10.12.2012Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice
10.12.2012J Exp Med 2012; 209:2485-99
Frebel Helge, Ludewig Burkhard, Kurrer Michael, Loffing-Cueni Dominique, Wagner Carsten A, Vogel Johannes, Richter Kirsten, Braunschweiler Thomas, Schuepbach Reto A, Nindl Veronika, Oxenius Annette